Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

US Patent 11951212 · Granted Apr 9, 2024

Estimated economic value: $281,571,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceut2025
Modulators of alpha-1 antitrypsin2025
Crystalline forms of CFTR modulators2025
Pharmaceutical composition and administrations thereof2025
Pharmaceutical composition and administrations thereof2025
Inhibitors of APOL1 and methods of using same2024
Modulators of alpha-1 antitrypsin2024
Crystalline forms of CFTR modulators2024
Pharmaceutical composition and administrations thereof2023
Pharmaceutical composition and administrations thereof2023
Modulators of alpha-1 antitrypsin2023
Inhibitors of APOL1 and methods of using same2023